Researchers link supplement to reduced biomarkers of Alzheimer's

For the first time, a researcher at the University of Delaware College of Health Sciences in collaboration with a team at the National Institute on Aging, a division of the National Institutes of Health, has determined that the naturally occurring dietary supplement known as nicotinamide riboside (NR) can enter the brain.

The associations of serum vitamin D status and vitamin D supplements use with all-cause dementia, Alzheimer's disease, and vascular dementia: a UK Biobank based prospective cohort study - The American Journal of

Frontiers Natural Therapeutics in Aid of Treating Alzheimer's Disease: A Green Gateway Toward Ending Quest for Treating Neurological Disorders

Biomarkers for Alzheimer's Disease

β-Amyloid, Tau, Neurodegeneration Classification and Eligibility for Anti-amyloid Treatment in a Memory Clinic Population

TaubCONNECT Research Perspectives

Imaging biomarkers in neurodegeneration: current and future practices, Alzheimer's Research & Therapy

IJMS, Free Full-Text

Frontiers Nicotinamide as potential biomarker for Alzheimer's disease: A translational study based on metabolomics

Researchers link supplement to reduced Alzheimer's biomarkers in brain

Biomarkers in Alzheimer's disease: role in early and differential diagnosis and recognition of atypical variants, Alzheimer's Research & Therapy